Return to homepagePandemic Pact

RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES -TASK ORDER 06

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 75N92022D00010-P00002-759202300004-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023
    2024

  • Known Financial Commitments (USD)

    $125,000

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    VICE PRESIDENT Rebekah Neal

  • Research Location

    United States of America

  • Lead Research Institution

    VENTUREWELL

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program was established to accelerate regulatory review and availability of high-quality, accurate, and reliable diagnostic tests. This project generated evidence to support regulatory filings with the US FDA to attain Emergency Use Authorizations for 2 over-the-counter SARS-CoV-2 diagnostic products.